[
Abstract]
[
Full Text HTML]
[
Full Text PDF] （in Japanese / 45KB）
[Members Only] J.Jpn. Surg. Soc.. 106(7): 427-430, 2005
Feature topic
STRATEGY FOR THE TREATMENT OF HEPATOBLASTOMA IN CHILDREN
Hepatoblastoma is the most common malignant live tumor in childhood. Multicenter trials have made it clear that pre- and/or postoperative chemotherapy are necessary to improve the outcome of the treatment of hepatoblastoma. The results of the Japanese Pediatric Liver Tumor (JPLT)-1 study since 1991 have been compatible with those of other group study trials in Europe and the USA. However, patients with unrsectable primary tumors or with lung metastasis still have a poor prognosis. The JPLT has developed a new protocol that includes four courses of treatment based on the PRETEXT staging system. These treatments include intensive chemotherapy with stem cell transplantation for patients with unresectable primary tumors or with pulmonary metastases.
To read the PDF file you will need Adobe Reader installed on your computer.